An antigenic substance produced in tumour cells, which triggers an immune response in the host.
ChEBI ID: 144829
| Member | Definition | Class |
|---|---|---|
| cefoxitin | A non-proteinogenic L-amino acid that is N-acetyl-alpha-D-galactosamine linked via an alpha glycosidic bond to the O at position 3 of L-serine. | O-(N-acetyl-alpha-D-galactosaminyl)-L-serine |
| n-glycolylneuraminyllactosylceramide | A sialotriaosylceramide in which the triaosyl group is 3,5-dideoxy-5-(2-hydroxyacetamido)-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranosyl attached to the primary hydroxy function of ceramide. A tumour antigen found in solid tumors such as breast carcinoma, nonsmall cell lung cancer, and melanoma, but not usually detected in normal human cells. | N-glycolylneuraminyllactosylceramide |
| Timeframe | Studies, Drugs with This Role(%) | All Drugs % |
|---|---|---|
| pre-1990 | 34 (7.33) | 18.7374 |
| 1990's | 130 (28.02) | 18.2507 |
| 2000's | 111 (23.92) | 29.6817 |
| 2010's | 155 (33.41) | 24.3611 |
| 2020's | 34 (7.33) | 2.80 |
| Publication Type | Studies, Drugs with this Role (%) | All Drugs (%) |
|---|---|---|
| Trials | 9 (1.86%) | 5.53% |
| Reviews | 36 (7.42%) | 6.00% |
| Case Studies | 9 (1.86%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 431 (88.87%) | 84.16% |